Top Markets
Coin of the day
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.

AURX
Peringkat dalam Saham #25548
Nuo Therapeutics, Inc. operates as a regenerative medicine company,... Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.
Harga Saham
$1.00
Terakhir disinkronkan: 2026-08-19
Kapitalisasi Pasar
$48.41M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-41.86%
Negara
US
Perdagangan Nuo Therapeutics, Inc. (AURX)

Kategori

Harga AURX dengan kapitalisasi pasar B
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
AURX
$1.00
Kapitalisasi pasar dari Nuo Therapeutics, Inc.(AURX)
Kapitalisasi Pasar: $48.41M
Per August 2026, Nuo Therapeutics, Inc. memiliki kapitalisasi pasar sebesar $48.41M. Ini menjadikan Nuo Therapeutics, Inc. sebagai perusahaan 25548th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Nuo Therapeutics, Inc. dari 2017 hingga 2026
AURX dibandingkan dengan 5 teratas stocks paling populer
Harga AURX Aset B Pasar B Hasil
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$108,592 $48.41M
$5.257T +10,859,108.56%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$94,995.50 $48.41M
$4.599T +9,499,449.68%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$84,830.71 $48.41M
$4.107T +8,482,970.80%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$73,896.21 $48.41M
$3.577T +7,389,521.11%
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.
$57,991.20 $48.41M
$2.807T +5,799,020.33%